Dendreon

PROVENGE

View Prices
  1. Home
    2.  / 
  2. Q Code
    3.  / PROVENGE – Q2043

Manufacturer:

Dendreon

Name:

PROVENGE

HCPCS Code Descriptor:

Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion

Category:

Q Code

HCPCS:

Q2043

NDC(s):

30237-8900-06

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

PROVENGE is an Oncology drug manufactured by Dendreon and administered via the Intravenous route of administration. The Q Code: Q2043 is aligned to the drug PROVENGE.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/11

HCPCS Effective Date:

7/1/11

HCPCS Short Description:

Sipuleucel-t auto cd54+

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.dendreononcall.com/